RANK Ligand Blocking Activity [MoA] - N0000187054

Pharmacologic Code	N0000187054
Pharmacologic Name	RANK Ligand Blocking Activity
Pharmacologic Uses	RANK ligand (RANKL) inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 9 products whose active ingredient are classified under the same pharmacologic class RANK Ligand Blocking Activity [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	55513-710	Prolia	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Amgen, Inc	ACTIVE
	55513-730	Xgeva	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Amgen, Inc	ACTIVE
	61314-228	Wyost	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Sandoz Inc	ACTIVE
	61314-240	Jubbonti	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Sandoz Inc	ACTIVE
	65219-668	Conexxence	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
	65219-670	Bomyntra	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
	65219-672	Bomyntra	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
	72606-037	Stoboclo	Non-Proprietary Name: Denosumab-bmwo	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
	72606-038	Osenvelt	Non-Proprietary Name: Denosumab-bmwo	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE